• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠中过氧化物酶体增殖物激活受体α的缺失会增强蛋氨酸和胆碱缺乏饮食诱导的脂肪性肝炎。

Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis.

作者信息

Kashireddy Papreddy V, Rao M Sambasiva

机构信息

Department of Pathology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Avenue, Chicago, IL 60611, USA.

出版信息

Hepatol Res. 2004 Oct;30(2):104-110. doi: 10.1016/j.hepres.2004.06.004.

DOI:10.1016/j.hepres.2004.06.004
PMID:15519275
Abstract

Pathogenesis of steatohepatitis, a common liver disease, remains controversial. It is proposed that fatty liver with a second hit capable of inducing necroinflammation results in nonalcoholic steatohepatitis. Long chain and very long chain fatty acids are considered important in induction of steatohepatitis. Peroxisome proliferator-activated receptor alpha (PPARalpha) plays an important role in beta-oxidation of long chain and very long chain fatty acids and mitogenic effect caused by peroxisome proliferators in the liver. To determine the role of PPARalpha in the pathogenesis of steatohepatitis and compensatory liver cell hyperplasia, we have used PPARalpha null mice and methionine and choline deficient nutritional model. Male and female PPARalpha null mice and wild type mice were fed methionine and choline deficient diet (MCDD) or normal chow for 4 weeks. Livers were analyzed morphologically for steatosis, steatohepatitis and hepatocyte proliferation (PCNA labeling) and biochemically for triglyceride levels. In addition, serum alanine transaminase, aspartate transaminase and triglyceride levels were measured. In MCDD fed PPARalpha null mice there was severe steatohepatitis and very high liver triglyceride levels compared to wild type mice. Serum aspartate transaminase levels were also significantly higher in MCDD fed PPARalpha null mice compared to wild type mice. The severity of steatohepatitis in MCDD fed male and female PPARalpha null mice was greater compared to wild type mice fed the same diet. The PCNA labeling index was similar in PPARalpha null mice and wild type mice fed MCDD, and significantly higher in both the groups compared to the mice fed control diet. These findings indicate that defective fatty acid oxidation aggravates steatohepatitis caused by methionine and choline deficiency and further establishes the role of long chain and very long chain fatty acids in the pathogenesis of steatohepatitis. In addition, the results of this study also indicate that there is no difference between males and females in the severity of steatohepatitis induced by MCDD and lack of PPARalpha does not affect compensatory hyperplasia in the liver.

摘要

脂肪性肝炎是一种常见的肝脏疾病,其发病机制仍存在争议。有人提出,伴有能够诱导坏死性炎症的二次打击的脂肪肝会导致非酒精性脂肪性肝炎。长链和极长链脂肪酸被认为在脂肪性肝炎的诱导中起重要作用。过氧化物酶体增殖物激活受体α(PPARα)在长链和极长链脂肪酸的β氧化以及过氧化物酶体增殖物在肝脏中引起的促有丝分裂作用中发挥重要作用。为了确定PPARα在脂肪性肝炎发病机制和代偿性肝细胞增生中的作用,我们使用了PPARα基因敲除小鼠以及蛋氨酸和胆碱缺乏的营养模型。将雄性和雌性PPARα基因敲除小鼠及野生型小鼠喂食蛋氨酸和胆碱缺乏饮食(MCDD)或正常食物4周。对肝脏进行形态学分析以检测脂肪变性、脂肪性肝炎和肝细胞增殖(PCNA标记),并进行生化分析以检测甘油三酯水平。此外,还测量了血清丙氨酸转氨酶、天冬氨酸转氨酶和甘油三酯水平。与野生型小鼠相比,喂食MCDD的PPARα基因敲除小鼠出现严重的脂肪性肝炎且肝脏甘油三酯水平非常高。与野生型小鼠相比,喂食MCDD的PPARα基因敲除小鼠血清天冬氨酸转氨酶水平也显著更高。与喂食相同饮食的野生型小鼠相比,喂食MCDD的雄性和雌性PPARα基因敲除小鼠的脂肪性肝炎严重程度更高。喂食MCDD的PPARα基因敲除小鼠和野生型小鼠的PCNA标记指数相似,且与喂食对照饮食的小鼠相比,两组的PCNA标记指数均显著更高。这些发现表明,脂肪酸氧化缺陷会加重蛋氨酸和胆碱缺乏引起的脂肪性肝炎,并进一步证实了长链和极长链脂肪酸在脂肪性肝炎发病机制中的作用。此外,本研究结果还表明,MCDD诱导的脂肪性肝炎严重程度在雄性和雌性之间没有差异,且缺乏PPARα不影响肝脏的代偿性增生。

相似文献

1
Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis.小鼠中过氧化物酶体增殖物激活受体α的缺失会增强蛋氨酸和胆碱缺乏饮食诱导的脂肪性肝炎。
Hepatol Res. 2004 Oct;30(2):104-110. doi: 10.1016/j.hepres.2004.06.004.
2
Sex differences in choline-deficient diet-induced steatohepatitis in mice.胆碱缺乏饮食诱导的小鼠脂肪性肝炎中的性别差异。
Exp Biol Med (Maywood). 2004 Feb;229(2):158-62. doi: 10.1177/153537020422900204.
3
Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.PPARα 依赖性肝脏脂质周转在小鼠饮食性脂肪性肝炎中的核心作用
Hepatology. 2003 Jul;38(1):123-32. doi: 10.1053/jhep.2003.50307.
4
Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.膳食鱼油激活过氧化物酶体增殖物激活受体α可减轻脂肪变性,但由于肝脏脂质过氧化物积累,无法预防实验性脂肪性肝炎。
J Gastroenterol Hepatol. 2008 Feb;23(2):267-75. doi: 10.1111/j.1440-1746.2007.05157.x. Epub 2007 Sep 12.
5
The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.忍冬乙醇提取物对蛋氨酸和胆碱缺乏饮食喂养的动物模型的非酒精性脂肪性肝炎具有改善作用。
Nutrients. 2015 Oct 21;7(10):8670-84. doi: 10.3390/nu7105423.
6
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
7
Inhibition of aldose reductase ameliorates diet-induced nonalcoholic steatohepatitis in mice via modulating the phosphorylation of hepatic peroxisome proliferator-activated receptor α.抑制醛糖还原酶通过调节肝脏过氧化物酶体增殖物激活受体α的磷酸化改善饮食诱导的小鼠非酒精性脂肪性肝炎。
Mol Med Rep. 2015 Jan;11(1):303-8. doi: 10.3892/mmr.2014.2713. Epub 2014 Oct 21.
8
Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis.促进蛋氨酸和胆碱缺乏时肝内脂肪酸蓄积的代谢途径:与脂肪性肝炎发病机制的关系。
Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E402-9. doi: 10.1152/ajpendo.00331.2010. Epub 2010 Nov 30.
9
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.Toll 样受体 2 缺陷增强非酒精性脂肪性肝炎。
BMC Gastroenterol. 2010 May 28;10:52. doi: 10.1186/1471-230X-10-52.
10
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

引用本文的文献

1
NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models.非酒精性脂肪性肝病相关性肝癌:聚焦最新相关临床前模型
Cancers (Basel). 2023 Jul 22;15(14):3723. doi: 10.3390/cancers15143723.
2
Customized liver organoids as an advanced modeling and drug discovery platform for non-alcoholic fatty liver diseases.定制化的肝脏类器官作为一种先进的非酒精性脂肪性肝病建模和药物发现平台。
Int J Biol Sci. 2023 Jul 9;19(11):3595-3613. doi: 10.7150/ijbs.85145. eCollection 2023.
3
Knockout of Purinergic P2Y Receptor Fails to Improve Liver Injury and Inflammation in Non-Alcoholic Steatohepatitis.
嘌呤能 P2Y 受体敲除未能改善非酒精性脂肪性肝炎中的肝损伤和炎症。
Int J Mol Sci. 2023 Feb 14;24(4):3800. doi: 10.3390/ijms24043800.
4
Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat.祛湿化瘀方对MCD饮食诱导的大鼠非酒精性脂肪性肝炎的肝保护作用
Chin Med. 2021 Mar 16;16(1):27. doi: 10.1186/s13020-021-00434-1.
5
Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview.实用肝脏细胞生物学方法的最新进展:简要概述。
Int J Mol Sci. 2020 Mar 16;21(6):2027. doi: 10.3390/ijms21062027.
6
From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations.从整体到肝细胞模型的肝甘油三酯代谢:人类必须认识到自己的局限性。
Am J Physiol Endocrinol Metab. 2015 Jan 1;308(1):E1-20. doi: 10.1152/ajpendo.00192.2014. Epub 2014 Oct 28.
7
Molecular pathways in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的分子途径
Clin Exp Gastroenterol. 2014 Jul 5;7:221-39. doi: 10.2147/CEG.S62831. eCollection 2014.
8
Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion.缺氧诱导的脂滴相关蛋白(HILPDA)是一种新型的过氧化物酶体增殖物激活受体(PPAR)靶点,参与肝脏甘油三酯分泌。
J Biol Chem. 2014 Jul 11;289(28):19279-93. doi: 10.1074/jbc.M114.570044. Epub 2014 May 29.
9
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.一种能够快速在非酒精性脂肪性肝炎中发展出肝纤维化的改良小鼠模型。
Int J Exp Pathol. 2013 Apr;94(2):93-103. doi: 10.1111/iep.12008. Epub 2013 Jan 11.
10
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的动物模型。
World J Gastroenterol. 2012 May 21;18(19):2300-8. doi: 10.3748/wjg.v18.i19.2300.